TJX — The TJX Companies, Inc.

The tape and the sell-side are telling opposite stories. As of 2026-09-13 the stock sat at $126.03, down 25.2% over three months and 18.3% below its 200-day moving average, with RSI(14) at 17.79 — a level reached only in genuine panics. Yet the analyst community still shows 44 Buy ratings, 7 Holds and just 1 Sell, with a $174.15 average price target. The disconnect is a multiple reset, not an earnings miss: TJX hit an all-time high of $170 in June 2026 (roughly 32–33x forward EPS) and has been re-rated toward ~24x forward since, helped along by late-August caution from houses such as Citigroup (downgrade to Neutral) citing valuation ceilings and macro headwinds. Sentiment is bearish because the market is repricing what it will pay for the earnings, not because the earnings stopped coming.

Revenue grew steadily through the period, then decelerated: YoY growth ran -0.4% (Q4 FY25, a 53-week comparison distortion), +5.1%, +6.9%, +7.5%, +8.5%, +9.3%, then +5.4% in Q2 FY27 ($15.18B vs $14.40B). That is a real deceleration, but off a very strong base — Q2 FY27's 4% comp was driven by both higher baskets and higher transaction counts, which is the healthy version of retail growth. Margins are the standout and the story is consistent, not a one-quarter blip: operating margin went 11.67% (Q3 FY25) → 11.30% → 10.04% → 11.25% → 13.05% → 13.27% → 11.77% → 13.09% (Q2 FY27), with gross margin jumping to 33.4% from 30.7% a year earlier (+268 bps). EPS has followed: $1.36 diluted in Q2 FY27 vs $1.10 a year ago (+24%, per FMP; the research brief cites $1.22 reported / $1.36 adjusted — a discrepancy worth reconciling against the 10-Q, but the direction is up under either reading). The important caveat: management itself attributes part of the raised FY27 guidance to tariff refund receipts, i.e. a non-recurring tailwind inside the margin line. Note also that FY27 guidance of $5.15–$5.20 against FY26's $4.88 is only +5.5% to +6.6%, and implies flat-to-down H2 FY27 EPS versus a very strong H2 FY26 — growth is decelerating off a peak, not accelerating.

Fair, at the lower end of fair. As of 2026-09-13, TJX traded at 23.3x trailing EPS of $5.432 and 2.23x sales — the P/S is dead-on its 5-year average of 2.20x, while the P/E sits ~15% below its 5-year average of 27.5x. On forward numbers, $126.03 ÷ $5.175 (FY27 guidance midpoint) = 24.4x; on FMP's next-FY consensus EPS of $5.283, it's 23.9x. So the stock has gone from a premium multiple (32x+ in June 2026) to roughly in-line-to-slightly-cheap versus its own recent history. The PEG of 1.027 looks attractive but is misleading — it is computed off a ~23% trailing EPS growth rate that is not sustainable given guidance implies mid-single-digit growth. Compared to where TJX traded pre-2021 (~20–22x), 24x is not cheap; compared to the 27.5x five-year average, it is. Fair is the honest answer.

This is the cleanest version of a 'price down, earnings up' setup: the stock fell 25% while management RAISED full-year EPS guidance. That means essentially 100% of the drawdown is multiple compression, not estimate cuts — normally a favorable asymmetry for a patient buyer. The catch is what earnings power you underwrite. FY27 guidance of $5.15–$5.20 implies only ~6% growth over FY26's $4.88, and FMP's next-FY estimate of $5.283 implies roughly 2% growth on top of that — a big step down from the +24% TTM EPS print. If the recent margin expansion (helped by tariff refunds) proves structural, 24x forward is too cheap and the stock re-rates. If it proves to be a peak-quarter artifact, 24x forward is full price for a low-single-digit grower. Watch the gross margin line in the Nov 18 print before assuming the beat rate continues.

As of 2026-09-13, the technical picture is unambiguously bearish and not yet a buy signal. RSI(14) stood at 17.79 — deeply oversold, below 20, which is rare — with the price 7.88% below its 20-day SMA, 14.86% below its 50-day, and 18.33% below its 200-day. Backing those percentages out to dollar levels gives roughly $137 (20-day), $148 (50-day) and $154 (200-day), all far overhead. Returns: -4.59% one week, -17.42% one month, -25.17% three months, -18.92% six months — a persistent downtrend, not a one-day flush. Oversold in an intact downtrend is a condition, not a catalyst. Timing implication: wait for evidence of a base — either a retest that holds the $124.87 52-week low, or a reclaim of the 20-day SMA near $137 — rather than catching the falling knife on RSI alone.

• Value-seeking consumer: persistent inflation and wallet pressure push shoppers from full-price department stores to off-price, a structural tailwind for TJX banners — but a weakening labor market would eventually shrink the whole pie.
• Tariff and import-cost volatility: TJX's Q2 FY27 margin beat was partly tariff refund receipts; new tariffs or the end of refunds would compress merchandise margin and reverse part of the recent earnings quality improvement.
• Labor and wage costs: minimum-wage pressure across the store base is a structural, hard-to-hedge cost headwind for a company with thousands of physical locations.
• Rates and low-beta positioning: TJX's beta of 0.593 makes it a defensive holding — falling rates and steady consumer confidence would help a re-rating, while a risk-off rotation into defensives could stop the bleeding independent of fundamentals.
• Sector rotation out of premium-multiple consumer compounders: the entire drawdown is consistent with the market paying less for quality growth across retail, meaning TJX's multiple could keep compressing even if comps stay at 4%.
• International/FX exposure via TK Maxx in Europe and Australia, where currency swings flow straight into reported revenue growth.

• Q3 FY27 earnings on Wednesday, November 18, 2026 (pre-market): consensus EPS $1.35; the focus will be back-to-school conversion, holiday inventory positioning, and whether Q4/FY27 guidance holds at $5.15–$5.20 or gets raised again.
• Segment mix shift toward HomeGoods, which posted roughly 7% comps in Q2 FY27 — the highest-margin, fastest-growing banner and the best evidence that the off-price model is still taking share.
• Accelerated share repurchases — $355.19 million completed under the February 2026 authorization — which mechanically lifts EPS and, by shrinking equity ($10.65B), flatters ROE and P/B optics.
• The FY28 start of ~4% annual unit growth toward a long-term ~7,500-store global footprint, a multi-year square-footage runway that supports mid-single-digit revenue growth without comp heroics.
• A potential multiple re-rating if Q3 comps hold at or above 4% and gross margin proves durable ex-tariff-refunds — the market currently prices in the opposite.

• The de-rating may not be finished: even at ~24x forward, TJX sits above its pre-2021 norm of roughly 20–22x; if EPS growth settles in the low single digits, a 20x multiple on $5.30 implies about $106 per share.
• Earnings quality risk from one-time items: tariff refund receipts flattered the Q2 FY27 margin and the raised FY27 guidance, and a reversal would hit both reported margins and the credibility of the beat streak.
• Deceleration is real, not just optics: revenue growth fell from +9.3% (Q1 FY27) to +5.4% (Q2 FY27), and FMP's next-FY EPS estimate of $5.283 implies only ~2% growth off FY27 guidance — a much weaker forward earnings slope than the +24% TTM print suggests.
• Consumer macro deterioration: any meaningful rise in unemployment or consumer credit stress would undercut the trade-down thesis that has driven TJX's traffic.
• Structural cost pressure from wages, freight, and supply-chain inflation that TJX cannot fully offset through buying discipline.
• If the revenue/EPS discrepancy between the FMP diluted figure ($1.36) and the brief's reported figure ($1.22) reflects a larger-than-expected GAAP/adjusted gap, the headline quality of the beat is overstated.

TJX is a genuinely high-quality business — 21.5% ROIC, ~$5.9B of TTM free cash flow, a negative accruals ratio (-1.9%) confirming earnings are backed by cash, and consistent multi-quarter gross margin expansion to 33.4% — that has been repriced by the market for reasons that are almost entirely about the multiple, not the operations. Comps are +4%, guidance was raised, and the stock is at a 52-week low with RSI under 18. That is an interesting setup, but not an unambiguous one: 24x forward is not cheap versus TJX's own pre-2021 norm, the trailing +24% EPS growth is not repeatable, and the tape shows no base yet. I would treat $126 as a reasonable place to start a position, not to back up the truck — add on a successful retest of $124.87 or on a clean Q3 print on November 18.

Justified forward P/E method: I applied a 25.0x multiple to a next-twelve-months EPS estimate of $5.32 (blending FY27 guidance of $5.175 with FMP's next-FY consensus of $5.283), producing $133.00. The 25x is a deliberate ~9% discount to TJX's 5-year average P/E of 27.5x, justified by revenue growth decelerating from +8.5% to +5.4% and by the one-time tariff-refund component of recent margin gains, but held above the broader market and above TJX's own pre-2021 norm because of the 21.5% ROIC, 0.59 beta, and counter-cyclical trade-down demand. This sits ~5% above the 2026-09-13 price of $126.03 and far below the $174.15 stale sell-side consensus, consistent with a Neutral lean.